MHRA and West Midlands Police Seize £2 Million in Counterfeit Weight Loss Pens
The Medicines and Healthcare products Regulatory Agency (MHRA) announced that officers, working alongside West Midlands Police, seized approximately £2 million worth of fake weight loss medicines on October 14, 2026. The raid at an industrial unit in Birmingham uncovered over 12,000 counterfeit retatrutide and tirzepatide pens, as well as packaging for roughly 30,000 more products. The MHRA stated that retatrutide is not authorised for use in the UK, making sales outside approved clinical trials illegal. This announcement matters to the public because fake medicines bought from unregulated sources have not been evaluated for safety or quality. There is no guarantee regarding what ingredients they contain or whether they are contaminated with harmful substances. The agency advises anyone seeking GLP-1 weight loss treatments to consult a healthcare professional and only obtain prescription medicines through a registered pharmacy.
What was announced
The Medicines and Healthcare products Regulatory Agency (MHRA) and West Midlands Police raided an industrial unit in Birmingham on October 14, 2026. They seized over 12,000 fake retatrutide and tirzepatide pens valued at about £2 million, alongside packaging for 30,000 additional items.
The MHRA reported that officers found the products in a filthy warehouse. Retatrutide is currently unauthorised in the UK. The agency also listed three previous enforcement actions targeting illegal GLP-1 weight loss products:
- May 2026: A raid on a country estate where officers arrested two people and recovered about 12,000 doses, packaging, and suspected pharmaceutical substances.
- February 2026: A seizure of around 2,000 doses, manufacturing equipment, ingredients, packaging, and commercial vehicles.
- October 2025: The dismantling of the first illicit weight loss medicine production facility found in the UK, recovering 5,000 fake pens, empty pens, and raw chemicals.
What it means
Unauthorised weight loss products pose public health risks. Because the MHRA has not assessed these items for safety, quality, or effectiveness, users cannot verify their contents or know if they contain dangerous contaminants.
The MHRA warns people not to buy weight loss medicines from unregulated online sellers. Patients considering GLP-1 treatments should speak with a doctor, nurse, or pharmacist, and obtain medicines only from a registered pharmacy with a valid prescription. Anyone who suspects a side effect from a medicine can report it to a healthcare provider and submit a report to the MHRA Yellow Card scheme.
What the announcement does not tell us
The MHRA announcement does not state whether officers made any arrests during the October 14 raid in Birmingham. It does not name the specific websites, social media accounts, or sellers that distributed the seized counterfeit pens. Additionally, the release does not detail the exact chemical contents found inside the confiscated fake pens, nor does it give a timeline for when retatrutide might complete UK regulatory reviews.
How this was written
This analysis was written with AI from the official announcement below, using only facts that announcement states. The quoted wording is gov.uk: Medicines and Healthcare products Regulatory Agency’s own. Always check the original before acting on anything here.
Fake weight loss medicines worth approximately £2 million were seized last night in a raid executed by the Medicines and Healthcare products Regulatory Agency (MHRA) and West Midlands Police.
Opens www.gov.uk
More from gov.uk: Medicines and Healthcare products Regulatory Agency
- MHRA sets out approach to strengthen patient and public involvement and engagement in medicines and medical device regulation5 November 2026
- MHRA guidance on its assessment of non-clinical data generated outside OECD system4 November 2026
- Clinical trials for medicines: Inclusion and Diversity Plan pilot findings published3 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.